Scharf Investments, LLC Novartis Ag Transaction History

Scharf Investments, LLC

$3.36 Billion
Q1 2024

A detailed history of Scharf Investments, LLC transactions in Novartis Ag stock. As of the latest transaction made, Scharf Investments, LLC holds 1,364,854 shares of NVS stock, worth $141 Million. This represents 3.93% of its overall portfolio holdings.

Number of Shares

1,364,854

Previous 1,423,720 4.13%

Holding current value

$141 Million

Previous $144 Million 8.16%

% of portfolio

3.93%

Previous 4.48%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$95.27 - $108.47 $5.61 Million - $6.39 Million	-58,866 Reduced 4.13%	1,364,854 $132 Million
Q4 2023 Jan 12, 2024	SELL	$92.27 - $101.54 $186,846 - $205,618	-2,025 Reduced 0.14%	1,423,720 $144 Million
Q3 2023 Oct 13, 2023	SELL	$94.73 - $105.13 $7.14 Million - $7.92 Million	-75,341 Reduced 5.02%	1,425,745 $145 Million
Q2 2023 Jul 24, 2023	SELL	$92.52 - $104.91 $11.6 Million - $13.1 Million	-124,889 Reduced 7.68%	1,501,086 $151 Million
Q1 2023 Apr 14, 2023	BUY	$80.03 - $92.81 $4.06 Million - $4.7 Million	50,682 Added 3.22%	1,625,975 $150 Million

Q4 2022 Feb 03, 2023	BUY	$75.55 - $92.52 $12.1 Million - $14.8 Million	159,673 Added 11.28%	1,575,293 $143 Million
Q3 2022 Oct 25, 2022	BUY	$74.61 - $87.26 $6.94 Million - $8.12 Million	93,014 Added 7.03%	1,415,620 $108 Million
Q2 2022 Jul 19, 2022	SELL	$80.52 - $93.75 $1.46 Million - $1.69 Million	-18,074 Reduced 1.35%	1,322,606 $112 Million
Q1 2022 Apr 13, 2022	BUY	$80.11 - $90.62 $6.3 Million - $7.12 Million	78,603 Added 6.23%	1,340,680 $118 Million
Q4 2021 Jan 20, 2022	BUY	$79.7 - $88.13 $1.38 Million - $1.53 Million	17,366 Added 1.4%	1,262,077 $110 Million
Q3 2021 Oct 14, 2021	SELL	$81.78 - $95.14 $1.46 Million - $1.7 Million	-17,882 Reduced 1.42%	1,244,711 $102 Million
Q2 2021 Jul 16, 2021	BUY	$85.24 - $94.15 $4.93 Million - $5.45 Million	57,893 Added 4.81%	1,262,593 $115 Million
Q1 2021 Apr 14, 2021	BUY	$83.5 - $98.47 $597,943 - $705,143	7,161 Added 0.6%	1,204,700 $103 Million
Q4 2020 Jan 20, 2021	SELL	$78.07 - $94.43 $1.16 Million - $1.4 Million	-14,815 Reduced 1.22%	1,197,539 $113 Million
Q3 2020 Oct 19, 2020	SELL	$82.14 - $91.0 $7.43 Million - $8.24 Million	-90,508 Reduced 6.95%	1,212,354 $105 Million
Q2 2020 Jul 16, 2020	SELL	$80.93 - $91.1 $2.21 Million - $2.49 Million	-27,313 Reduced 2.05%	1,302,862 $114 Million
Q1 2020 May 05, 2020	BUY	$70.67 - $99.01 $13.3 Million - $18.6 Million	188,354 Added 16.5%	1,330,175 $110 Million
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $3.05 Million - $3.44 Million	-36,118 Reduced 3.07%	1,141,821 $108 Million
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $8.61 Million - $9.48 Million	-100,618 Reduced 7.87%	1,177,939 $102 Million
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $30.6 Million - $37.6 Million	405,449 Added 46.44%	1,278,557 $117 Million
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $1.65 Million - $1.89 Million	-21,894 Reduced 2.45%	873,108 $83.9 Million
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $6.41 Million - $7.13 Million	86,972 Added 10.76%	895,002 $76.8 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $2.32 Million - $2.69 Million	34,708 Added 4.49%	808,030 $69.6 Million
Q2 2018 Aug 13, 2018	SELL	$64.91 - $73.36 $1.73 Million - $1.96 Million	-26,660 Reduced 3.33%	773,322 $58.4 Million
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $6.17 Million - $7.38 Million	-87,683 Reduced 9.88%	799,982 $64.7 Million
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $3.75 Million - $4.03 Million	-51,887 Reduced 5.52%	887,665 $74.5 Million
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $1.73 Million - $1.8 Million	-23,275 Reduced 2.42%	939,552 $80.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	962,827	962,827 $80.4 Million

Others Institutions Holding NVS

# of Institutions

1,342

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scharf Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scharf Investments, LLC with notifications on news.

Account

Scharf Investments, LLC Novartis Ag Transaction History